The Archimedes offering by Khashu and Balasubramaniam contains a serious error as well as a somewhat eccentric spelling of gelofusine.1 They suggest in their “Clinical bottom line” (bullet point 3) that “Weak evidence suggests an increased risk of necrotising enterocolitis with use of Gelofuscine [sic] in neonates. (Grade B)”. In fact there is no …